Biogen (BIIB) PT Slashed At RBC On Alzheimer's Prospects

March 25, 2019 7:12 AM
RBC Capital analyst, Brian Abrahams, reiterated his Sector Perform rating on shares of Biogen (NASDAQ: BIIB) and cut his price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)


Analyst Comments Analyst EPS Change Analyst PT Change

Next Articles